Common Contracts

5 similar Sales Agreement contracts by Provention Bio, Inc., Harmony Biosciences Holdings, Inc., Innovate Biopharmaceuticals, Inc., Kura Oncology, Inc.

HARMONY BIOSCIENCES HOLDINGS, INC. Shares of Common Stock ($0.00001 par value per share) SALES AGREEMENT
Sales Agreement • February 25th, 2025 • Harmony Biosciences Holdings, Inc. • Pharmaceutical preparations • New York

Harmony Biosciences Holdings, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Leerink Partners LLC and Cantor Fitzgerald & Co. (each an “Agent” and together, the “Agents”), as follows:

KURA ONCOLOGY, INC. COMMON STOCK SALES AGREEMENT
Sales Agreement • November 2nd, 2023 • Kura Oncology, Inc. • Pharmaceutical preparations • New York

Kura Oncology, Inc., a Delaware corporation (the “Company”), Leerink Partners LLC (“Leerink Partners”), as lead sales agent, and Cantor Fitzgerald & Co. (“Cantor”, and together with Leerink Partners, the “Agents”), as sales agent, confirm their agreement (this “Agreement”) as follows:

Provention Bio, Inc. Shares of Common Stock ($0.0001 par value per share) SALES AGREEMENT
Sales Agreement • February 26th, 2021 • Provention Bio, Inc. • Pharmaceutical preparations • New York

Provention Bio, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with SVB Leerink LLC and Cantor Fitzgerald & Co. (each individually, an “Agent” and collectively, the “Agents”), as follows:

Provention Bio, Inc. Shares of Common Stock ($0.0001 par value per share) SALES AGREEMENT
Sales Agreement • August 2nd, 2019 • Provention Bio, Inc. • Pharmaceutical preparations • New York

Provention Bio, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with SVB Leerink LLC and Cantor Fitzgerald & Co. (each individually, an “Agent” and collectively, the “Agents”), as follows:

INNOVATE BIOPHARMACEUTICALS, INC. COMMON STOCK SALES AGREEMENT
Sales Agreement • October 29th, 2018 • Innovate Biopharmaceuticals, Inc. • Pharmaceutical preparations • New York

Innovate Biopharmaceuticals, Inc., a Delaware corporation (the "Company"), confirms its agreement (this "Agreement") with H.C. Wainwright & Co., LLC ("HCW") and Ladenburg Thalmann & Co. Inc. ("Ladenburg", each of HCW and Ladenburg individually an "Agent" and collectively, the "Agents"), as follows: